A novel score system of blood tests for differentiating Kawasaki disease from febrile children

PLoS One. 2021 Jan 22;16(1):e0244721. doi: 10.1371/journal.pone.0244721. eCollection 2021.

Abstract

Background: Kawasaki disease is the most common cause of acquired heart disease among febrile children under the age of 5 years old. It is also a clinically diagnosed disease. In this study, we developed and assessed a novel score system using objective parameters to differentiate Kawasaki disease from febrile children.

Methods: We analyzed 6,310 febrile children and 485 Kawasaki disease subjects in this study. We collected biological parameters of a routine blood test, including complete blood count with differential, C-reactive protein, aspartate aminotransferase, and alanine aminotransferase. Receiver operating characteristic curve, logistic regression, and Youden's index were all used to develop the prediction model. Two other independent cohorts from different hospitals were used for verification.

Results: We obtained eight independent predictors (platelets, eosinophil, alanine aminotransferase, C-reactive protein, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and monocyte) and found the top three scores to be eosinophil >1.5% (score: 7), alanine aminotransferase >30 U/L (score: 6), and C-reactive protein>25 mg/L (score: 6). A score of 14 represents the best sensitivity value plus specificity prediction rate for Kawasaki disease. The sensitivity, specificity, and accuracy for our cohort were 0.824, 0.839, and 0.838, respectively. The verification test of two independent cohorts of Kawasaki disease patients (N = 103 and 170) from two different institutes had a sensitivity of 0.780 (213/273).

Conclusion: Our findings demonstrate a novel score system with good discriminatory ability for differentiating between children with Kawasaki disease and other febrile children, as well as highlight the importance of eosinophil in Kawasaki disease. Using this novel score system can help first-line physicians diagnose and then treat Kawasaki disease early.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aspartate Aminotransferases / blood
  • Blood Cell Count
  • C-Reactive Protein / analysis
  • Case-Control Studies
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Fever / blood
  • Fever / diagnosis*
  • Hematologic Tests
  • Humans
  • Infant
  • Logistic Models
  • Male
  • Mucocutaneous Lymph Node Syndrome / blood
  • Mucocutaneous Lymph Node Syndrome / diagnosis*
  • ROC Curve
  • Retrospective Studies

Substances

  • C-Reactive Protein
  • Aspartate Aminotransferases

Grants and funding

This study received funding from the following grants: MOST 108-2314-B-182 -037 -MY3 and MOST 103-2410-H-264-004 from the Ministry of Science and Technology of Taiwan and 8E0212 from Chang Gung Memorial Hospital, Taiwan. Although these institutes provided financial support, they had no influence on the way in which we collected, analyzed, or interpreted the data or wrote this manuscript.